TET 830 modified/T – helper epitope from tetanus toxoid

Product Name
TET 830 modified/T – helper epitope from tetanus toxoid
Description
A Phase I trial was carried out to assess both the safety and the immunological response of a melanoma vaccine. This vaccine incorporates the HLA-A2-restricted peptide YLEPGPVTA (gp100(280)), with the option of including a modified T-helper epitope sourced from tetanus toxoid, known as AQYIKANSKFIGITEL. AQYIKANSKFIGITEL, also referred to as TET 830 modified T-helper epitope from tetanus toxoid, serves as a universal human tetanus toxin T cell epitope. Its primary function is to induce T-cell activation, making it a valuable helper peptide in various vaccination strategies.
Product Quantity
5mg
Catalog Number
LT2290
Molecular Weight
1796.11
Formula
C83H134N20O24
Sequence
Ala-Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu, AQYIKANSKFIGITEL
  • 5 Units in Stock
Ask a Question

$285.12

Add to Cart: